Thursday, March 3, 2022

// // Leave a Comment

Merck's Covid Antiviral Gets WHO Backing for High-Risk Patients

Merck & Co.'s Covid-19 antiviral pill was endorsed by a World Health Organization panel for patients in the early stages of disease who face high risk of hospitalization. The WHO panel of international experts, which looked at data from six randomized ...

from Google Alert - health https://ift.tt/rZqhTob
via IFTTT

0 comments:

Post a Comment